EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.3.1.94 | Adenoma |
27045721 |
[Expression of enterotoxigenic Bacteroides fragilis and polyketide synthase gene-expressing Escherichia coli in colorectal adenoma patients]. |
ongoing research therapeutic application unassigned |
3 2 0 |
2.3.1.94 | Bacterial Infections |
31897537 |
Marine macroalgae-associated heterotrophic Firmicutes and Gamma-proteobacteria: prospective anti-infective agents against multidrug resistant pathogens. |
therapeutic application unassigned |
3 0 |
2.3.1.94 | Buruli Ulcer |
17031885 |
Ketoreduction in mycolactone biosynthesis: insight into substrate specificity and stereocontrol from studies of discrete ketoreductase domains in vitro. |
unassigned |
0 |
2.3.1.94 | Buruli Ulcer |
21072233 |
Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics. |
unassigned |
0 |
2.3.1.94 | Buruli Ulcer |
24392169 |
Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice. |
causal interaction therapeutic application unassigned |
1 2 0 |
2.3.1.94 | Buruli Ulcer |
30090691 |
IFN-? and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection. |
diagnostic usage ongoing research therapeutic application unassigned |
2 1 2 0 |
2.3.1.94 | Colorectal Neoplasms |
27571755 |
MATE transport of the E. coli-derived genotoxin colibactin. |
unassigned |
0 |
2.3.1.94 | Colorectal Neoplasms |
31129429 |
The Escherichia coli colibactin resistance protein ClbS is a novel DNA binding protein that protects DNA from nucleolytic degradation. |
unassigned |
0 |
2.3.1.94 | Colorectal Neoplasms |
31765952 |
Mucosal cancer-associated microbes and anastomotic leakage after resection of colorectal carcinoma. |
diagnostic usage therapeutic application unassigned |
4 1 0 |
2.3.1.94 | Colorectal Neoplasms |
34182940 |
Stool pattern is associated with not only the prevalence of tumorigenic bacteria isolated from fecal matter but also plasma and fecal fatty acids in healthy Japanese adults. |
therapeutic application unassigned |
2 0 |